New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx Medical Corporation Reports First Quarter 2026 Financial Results
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Renuvion wins 2026 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Apyx Medical Corporation (APYX) Q4 2025 Earnings Call Transcript
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference
Chuck Royce's Recent Transaction with Apyx Medical Corp: An In-Depth Analysis
Apyx Medical Corporation Reports Preliminary, Unaudited, Fourth Quarter and Full Year 2025 Revenue Results
Apyx Medical Corporation Announces Approval and Commercial Launch of Apyx One Console and Single-Use Handpieces for Cosmetic Surgical Procedures in South Korea
Apyx Medical Corporation Announces Pricing of $10 Million Public Offering of Common Stock
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Apyx Medical Corporation (APYX) Q3 2025 Earnings Call Transcript
Apyx Medical Corporation to Release Third Quarter of Fiscal Year 2025 Financial Results on November 6, 2025
Apyx Medical Corporation - Special Call
Apyx Medical Corporation (APYX) Q2 2025 Earnings Call Transcript
Apyx Medical Corporation Reports Second Quarter 2025 Financial Results
Apyx Medical Corporation to Participate in the Canaccord Genuity 45th Annual Growth Conference
Renuvion® Brings Real Transformations to the Runway at Miami Swim Week
Apyx Medical Corporation Receives FDA Clearance for the AYON Body Contouring System™
Apyx Medical Corporation (APYX) Q1 2025 Earnings Call Transcript
Renuvion Introduces Television Star Dolores Catania as Chief of Confidence
Apyx Medical Corporation Announces Two Peer-Reviewed Publications on the Use of Renuvion in Abdominal Body Contouring Procedures
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
Renuvion wins 2025 NewBeauty Award for "Best Minimally Invasive Skin Tightener"
Apyx Medical Corporation (APYX) Q4 2024 Earnings Call Transcript
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Apyx Medical Corporation Submits 510(k) Premarket Notification to the U.S. Food and Drug Administration for the AYON Body Contouring System™
Apyx Medical Corporation to Attend 15th Annual Craig-Hallum Alpha Select Conference
Apyx Medical Corporation (APYX) Q3 2024 Earnings Call Transcript
Apyx Medical (APYX) Reports Q3 Loss, Lags Revenue Estimates
Apyx Medical Corporation Announces $7,000,000 Million Registered Direct Offering
Apyx Medical Corporation Reports Third Quarter 2024 Financial Results; Updates Full Year 2024 Financial Outlook and Introduces Full Year 2025 Financial Outlook
Apyx Medical Corporation to Release Third Quarter Of Fiscal Year 2024 Financial Results on November 8, 2024
Apyx (APYX) Upgraded to Buy: Here's What You Should Know
Renuvion Named #1 Trusted Body Contouring Technology by Doctors*
Apyx Medical Corporation (APYX) Q2 2024 Earnings Call Transcript
Apyx Medical (APYX) Reports Q2 Loss, Lags Revenue Estimates
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
Apyx Medical Corporation (APYX) Q1 2024 Earnings Call Transcript
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users' Summit
Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript
Apyx Medical (APYX) Reports Q4 Loss, Tops Revenue Estimates
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook